Does RANOLAZINE Cause Neoplasm malignant? 98 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 98 reports of Neoplasm malignant have been filed in association with RANOLAZINE (Ranolazine). This represents 1.0% of all adverse event reports for RANOLAZINE.
98
Reports of Neoplasm malignant with RANOLAZINE
1.0%
of all RANOLAZINE reports
11
Deaths
16
Hospitalizations
How Dangerous Is Neoplasm malignant From RANOLAZINE?
Of the 98 reports, 11 (11.2%) resulted in death, 16 (16.3%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RANOLAZINE. However, 98 reports have been filed with the FAERS database.
What Other Side Effects Does RANOLAZINE Cause?
Death (692)
Myocardial infarction (610)
Stent placement (593)
Chest pain (592)
Angina pectoris (583)
Dizziness (517)
Dyspnoea (348)
Cerebrovascular accident (334)
Fall (299)
Off label use (270)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which RANOLAZINE Alternatives Have Lower Neoplasm malignant Risk?
RANOLAZINE vs RAPAMUNE
RANOLAZINE vs RASAGILINE
RANOLAZINE vs RASBURICASE
RANOLAZINE vs RAVULIZUMAB
RANOLAZINE vs RAVULIZUMAB-CWVZ